Clinical studies recruiting near Valladolid

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Foot Muscles Training in Sclerosis
NA · Universidad de Valladolid · Inés Llamas-Ramos · NCT06665607 Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · Valladolid University Hospital · Joseph Broderick, MD · NCT07227246 Impact of Prehabilitation and Comprehensive Follow-up in Women With Breast Cancer
NA · Hospital Recoletas Campo Grande · European University Miguel de Cervantes · NCT07467824 Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.
Phase N/A · Hospital Clínico Universitario de Valladolid (HCUV) · Spanish Oncology Genito-Urinary Group · NCT06724159 Trastuzumab Deruxtecan in First-Line HER2-Positive Metastatic Breast Cancer With Proactive Toxicity Management
Phase 2 · Hospital Clínico Universitario de Valladolid · SOLTI Breast Cancer Research Group · NCT07371585 Reduction of the Incidence of NAV in Neonatal Units (INBERNAV-Neo)
Phase N/A · Hospital Universitario Río Hortega · Biobizkaia Health Research Institute · NCT07240038 Adjuvant Tebentafusp in High Risk Ocular Melanoma
Phase 3 · Hospital Clinico Universitario De Valladolid · European Organisation for Research and Treatment of Cancer - · NCT06246149 A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in
Phase N/A · Hospital Clinico Universitario de Valladolid · Hoffmann-La Roche · NCT07284121 Effect of Continued Nutritional Support at Hospital Discharge on Mortality, Frailty, Functional Outcomes and Recovery
NA · Hospital Clínico Universitario de Valladolid · Philipp Schuetz · NCT04926597 RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures
NA · Valladolid University Clinic Hospital · AgNovos Healthcare, LLC · NCT04796350 Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
Phase 2/Phase 3 · Hospital Universitario Rio Hortega · Exciva GmbH · NCT07284472 Use of Transcranial Direct Current Stimulation (TDCS) in an Active Pain Coping Program for Patients With Fibromyalgia: A
NA · Unidad de Estrategias de Afrontamiento Activo del Dolor. · University of Valladolid · NCT07239427 Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously
Phase 3 · Hospital Clínico Universitario de Valladolid · Fundación GECP · NCT06431633 A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Phase 3 · Hospital Universitario Rio Hortega · Ipsen · NCT06016842 Clinical Trial on HIPEC With Mitomycin C in Colon Cancer Peritoneal Metastases (GECOP-MMC)
Phase 4 · Hospital Universitario Río Hortega · Hospital Universitario de Fuenlabrada · NCT05250648 Thoracic Tumours Register
Phase N/A · Hospital Clínico Universitario de Valladolid · Spanish Lung Cancer Group · NCT02941458 External Multicenter Validation of the APTTO Model for Prolonged APTT Using Clot Waveform Analysis
Phase N/A · Hospital Clínico Universitario de Valladolid · Instituto de Investigación Sanitaria de la Fundación Jiménez · NCT07418099 Comparison Between Bipolar Transurethral Resection of the Prostate and Moses Assisted Holmium Laser Enucleation of the P
NA · Hospital Universitario Río Hortega · Fundacio Puigvert · NCT06649357 Treatment of Breakpoint Cluster Region-Abelson (BCR-ABL) Negative ALL in Adults
NA · H. Clínico Universitario de Valladolid · PETHEMA Foundation · NCT04179929 Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial)
NA · Hospital Universitario Río Hortega · Fundación Instituto de Estudios de Ciencias de la Salud de C · NCT03711110 Safety and Effectiveness Study of SQ-Kyrin System for Functional Mitral Regurgitation in EU
NA · Hospital Clínico Universitario de Valladolid · Shanghai Shenqi Medical Technology Co., Ltd · NCT06823700 Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associate
Phase 3 · Hospital Universitario Rio Hortega · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05980949 OSIREAL - Osimertinib RWE on EGFRm NSCLC in Spain
Phase N/A · Research Site · AstraZeneca · NCT06068049 Early Transcatheter Mitral Valve Repair After Myocardial Infarction
NA · Hospital Clínico Universitario de Valladolid · Fundación para la Investigación Biosanitaria del Principado · NCT06282042 International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
Phase 3 · Hospital Clínico Universitario de Valladolid · University Hospital Muenster · NCT04043494 Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109 Azacytidine, Venetoclax Plus Minus Quizartinib for First Line Older/Unfit AML Patients (VENP-A-QUI)
Phase 3 · H. Río Hortega · PETHEMA Foundation · NCT07478991 A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants Wit
Phase 1 · Research Site · AstraZeneca · NCT06916806 Phase III Randomized International Open Label Clinical Trial of Treatment Intensification With Docetaxel Plus Apalutamid
Phase 3 · Hospital Clínico Universitario de Valladolid · Alianza multidisciplinar para la investigación de los tumore · NCT07333066 A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT
Phase 3 · Hospital Universitario Rio Hortega · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05511363

Look up another city

Look up another condition